Drug Type Small molecule drug |
Synonyms |
Target |
Action agonists |
Mechanism β3-adrenergic receptor agonists(Beta-3 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pollakisuria | Phase 1 | United States | - | |
Urinary Bladder, Overactive | Phase 1 | - | - | |
Urinary Bladder, Overactive | Phase 1 | - | - | |
Urinary Incontinence | Phase 1 | Canada | - | |
Urinary Incontinence | Phase 1 | United States | - | |
Urinary Incontinence | Phase 1 | - | - |